345 related articles for article (PubMed ID: 17130578)
1. Is it dietary insulin?
Vaarala O
Ann N Y Acad Sci; 2006 Oct; 1079():350-9. PubMed ID: 17130578
[TBL] [Abstract][Full Text] [Related]
2. Enteral virus infections in early childhood and an enhanced type 1 diabetes-associated antibody response to dietary insulin.
Mäkelä M; Vaarala O; Hermann R; Salminen K; Vahlberg T; Veijola R; Hyöty H; Knip M; Simell O; Ilonen J
J Autoimmun; 2006 Aug; 27(1):54-61. PubMed ID: 16757149
[TBL] [Abstract][Full Text] [Related]
3. T-cell reactivity to insulin peptide A1-12 in children with recently diagnosed type 1 diabetes or multiple beta-cell autoantibodies.
Marttila J; Huttunen S; Vaarala O; Suzuki K; Elliott JF; Närvänen A; Knip M; Simell O; Ilonen J
J Autoimmun; 2008 Sep; 31(2):142-8. PubMed ID: 18565729
[TBL] [Abstract][Full Text] [Related]
4. Early nutrition and immunity - progress and perspectives.
Calder PC; Krauss-Etschmann S; de Jong EC; Dupont C; Frick JS; Frokiaer H; Heinrich J; Garn H; Koletzko S; Lack G; Mattelio G; Renz H; Sangild PT; Schrezenmeir J; Stulnig TM; Thymann T; Wold AE; Koletzko B
Br J Nutr; 2006 Oct; 96(4):774-90. PubMed ID: 17010239
[TBL] [Abstract][Full Text] [Related]
5. Dysrulation of T cell peripheral tolerance in type 1 diabetes.
Tisch R; Wang B
Adv Immunol; 2008; 100():125-49. PubMed ID: 19111165
[TBL] [Abstract][Full Text] [Related]
6. Effect of coincident enterovirus infection and cows' milk exposure on immunisation to insulin in early infancy.
Vaarala O; Klemetti P; Juhela S; Simell O; Hyöty H; Ilonen J
Diabetologia; 2002 Apr; 45(4):531-4. PubMed ID: 12032629
[TBL] [Abstract][Full Text] [Related]
7. Dietary insulin as an immunogen and tolerogen.
Tiittanen M; Paronen J; Savilahti E; Virtanen SM; Ilonen J; Knip M; Akerblom HK; Vaarala O;
Pediatr Allergy Immunol; 2006 Nov; 17(7):538-43. PubMed ID: 17014631
[TBL] [Abstract][Full Text] [Related]
8. The gut as a regulator of early inflammation in type 1 diabetes.
Vaarala O
Curr Opin Endocrinol Diabetes Obes; 2011 Aug; 18(4):241-7. PubMed ID: 21681088
[TBL] [Abstract][Full Text] [Related]
9. Thymic self-antigens for the design of a negative/tolerogenic self-vaccination against type 1 diabetes.
Geenen V; Mottet M; Dardenne O; Kermani H; Martens H; Francois JM; Galleni M; Hober D; Rahmouni S; Moutschen M
Curr Opin Pharmacol; 2010 Aug; 10(4):461-72. PubMed ID: 20434402
[TBL] [Abstract][Full Text] [Related]
10. The gut immune system and type 1 diabetes.
Vaarala O
Ann N Y Acad Sci; 2002 Apr; 958():39-46. PubMed ID: 12021082
[TBL] [Abstract][Full Text] [Related]
11. Impact of genetic and non-genetic factors in type 1 diabetes.
Hawa MI; Beyan H; Buckley LR; Leslie RD
Am J Med Genet; 2002 May; 115(1):8-17. PubMed ID: 12116172
[TBL] [Abstract][Full Text] [Related]
12. CD8+ T cells in type 1 diabetes.
Tsai S; Shameli A; Santamaria P
Adv Immunol; 2008; 100():79-124. PubMed ID: 19111164
[TBL] [Abstract][Full Text] [Related]
13. Environmental factors in the pathogenesis of type 1 diabetes mellitus.
Knip M; Akerblom HK
Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 3():S93-100. PubMed ID: 10522815
[TBL] [Abstract][Full Text] [Related]
14. The role of low avidity T cells in the protection against type 1 diabetes: a modeling investigation.
Khadra A; Santamaria P; Edelstein-Keshet L
J Theor Biol; 2009 Jan; 256(1):126-41. PubMed ID: 18950644
[TBL] [Abstract][Full Text] [Related]
15. [Virus and insulin-dependent diabetes mellitus. Etiopathogenic perspectives].
Thivolet C; Trepo C
Pathol Biol (Paris); 1988 Feb; 36(2):182-6. PubMed ID: 3279388
[TBL] [Abstract][Full Text] [Related]
16. Use of a cocktail regimen consisting of soluble galectin-1, rapamycin and histone deacetylase inhibitor may effectively prevent type 1 diabetes.
Jiang GX; Cui YF; Zhong XY; Tai S; Liu W; Wang ZD; Shi YG
Arch Med Res; 2009 Jul; 40(5):424-6. PubMed ID: 19766909
[TBL] [Abstract][Full Text] [Related]
17. Reduced CD4+ T-cell-specific gene expression in human type 1 diabetes mellitus.
Orban T; Kis J; Szereday L; Engelmann P; Farkas K; Jalahej H; Treszl A
J Autoimmun; 2007 Jun; 28(4):177-87. PubMed ID: 17320348
[TBL] [Abstract][Full Text] [Related]
18. New prospects for immunotherapy at diagnosis of type 1 diabetes.
Pozzilli P; Leslie RD
Diabetes Metab Res Rev; 2009 May; 25(4):299-301. PubMed ID: 19405079
[TBL] [Abstract][Full Text] [Related]
19. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice.
Xia CQ; Peng R; Qiu Y; Annamalai M; Gordon D; Clare-Salzler MJ
Diabetes; 2007 Aug; 56(8):2116-23. PubMed ID: 17496235
[TBL] [Abstract][Full Text] [Related]
20. Early suppression of immune response pathways characterizes children with prediabetes in genome-wide gene expression profiling.
Elo LL; Mykkänen J; Nikula T; Järvenpää H; Simell S; Aittokallio T; Hyöty H; Ilonen J; Veijola R; Simell T; Knip M; Simell O; Lahesmaa R
J Autoimmun; 2010 Aug; 35(1):70-6. PubMed ID: 20356713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
